ProfileGDS5822 / ILMN_1214189
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 80% 64% 68% 78% 69% 69% 59% 78% 75% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1134.380
GSM1276600PDAC Late Ablation Control 237.164
GSM1276601PDAC Late Ablation Control 360.568
GSM1276602PDAC Late Ablation 1107.478
GSM1276603PDAC Late Ablation 249.569
GSM1276604PDAC Late Ablation 355.869
GSM1303940PDAC Late Ablation_anti-CTLA4 127.959
GSM1303941PDAC Late Ablation_anti-CTLA4 2150.378
GSM1303942PDAC Late Ablation_anti-CTLA4 3110.675